You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 253 No. 3, January 18, 1985 TABLE OF CONTENTS
  JAMA
  •  Online Features
  SPECIAL COMMUNICATION
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on Web of Science (40)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Drug Use and Expenditures in 1982

Carlene Baum, PhD; Dianne L. Kennedy, RPh, MPH; Mary B. Forbes, RPh; Judith K. Jones, MD, PhD

JAMA. 1985;253(3):382-386.


Abstract

This article provides national estimates of drug use and drug expenditures in 1982. Total outpatient drug exposure increased 5% from 1981 to 1982 and 28% from 1971 to 1982. Hydrochlorothiazide was the most frequently dispensed drug chemical and was contained in more than 5% of all 1982 prescriptions. Sixteen major therapeutic classes accounted for about 80% of drugstore and hospital expenditures for ethical pharmaceuticals. Hospitals spent around $3.0 billion and a third of this total was for anti-infectives administered for systemic effects. The prescription drug component of the consumer price index increased 11.7% in 1982, and consumers spent about $14.5 billion on prescriptions from retail pharmacies alone.

(JAMA 1985;253:382-386)



Author Affiliations

From the Division of Drug and Biological Product Experience, National Center for Drug and Biologics, Food and Drug Administration, Rockville, Md.


Footnotes

The opinions expressed in this paper are those of the authors and not necessarily those of the FDA. The authors also assume responsibility for the accurate transcription of all data and the mathematical calculations performed by the Drug Use Analysis Branch.

Reprint requests to Drug Use Analysis Branch, HFN-737, Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857 (Dr Baum).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Hypertension in Women: What is Really Known? The Women's Caucus, Working Group on Women's Health of the Society of General Internal Medicine
Anastos et al.
ANN INTERN MED 1991;115:287-293.
ABSTRACT  

Prescription Medications in Infancy and Early Childhood
Fosarelli et al.
Arch Pediatr Adolesc Med 1987;141:772-775.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.